Drug Profile
Ezetimibe/rosuvastatin - Ache
Alternative Names: rosuvastatin/ezetimibe - AcheLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Ache Laboratories
- Class Antihyperlipidaemics; Azetidines; Fluorobenzenes; Phenols; Propanols; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action Cholesterol absorption inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Dyslipidaemias; Hypercholesterolaemia
Most Recent Events
- 30 Jan 2019 Chemical structure information added